Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 28Active not recruiting 26Not yet recruiting 7Completed 7Withdrawn 2Terminated 2Suspended 2Enrolling by invitation 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 111Carboplatin 45Nivolumab 41Paclitaxel 34Cyclophosphamide 32Cisplatin 32Gemcitabine 30atezolizumab 27venetoclax 25Specimen Handling 25Magnetic Resonance Spectroscopy 24Pemetrexed 23fludarabine 22Docetaxel 22Biopsy 22Radiotherapy 21Ipilimumab 21Bevacizumab 21Azacitidine 21Radiosurgery 18Dexamethasone 18durvalumab 17Fluorouracil 17Cetuximab 16fludarabine phosphate 14Trastuzumab 14tislelizumab 13Leucovorin 13Cytarabine 13olaparib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Fluorodeoxyglucose F18 × 1 year × Clear all
NCT06125028 2026-04-28

LYMFOR

Pentixapharm AG

Phase 3 Terminated
8 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
8 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡